S
SyMap Medical
SyMap Medical is an innovative medical device company
About SyMap Medical
Symap Medical is a healthcare startup that operates in the global market, focusing on the treatment of hypertension, a condition that claims over 10 million lives annually worldwide. The company's primary offering is a non-pharmaceutical treatment known as Renal Denervation (RDN). This technology, which has been in use since 2009, has gained increasing trust and attention due to advancements in RDN devices and techniques, as well as successful clinical trials.
Symap Medical serves a broad range of clients, primarily patients suffering from hypertension. The company's business model revolves around the provision of RDN treatment, which is a minimally invasive procedure that uses radiofrequency energy to disrupt the nerves in the renal arteries, thereby reducing blood pressure.
The company generates revenue by providing this treatment to patients. It also invests in research and development to further improve the RDN technology and optimize its effectiveness. In 2017, the company's research team, led by Ge Junbo, Huo Yong, and Sun Ningling, introduced the concept of "Drug Load Index" to assess the therapeutic response after RDN, a concept that was later adopted by other researchers.
Symap Medical's work has been recognized by the global medical community, with its clinical trial results published in the prestigious Lancet journal. The trial demonstrated that RDN treatment significantly reduced all blood pressure parameters in patients three months post-procedure, compared to a control group.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES EOther financing | Dec 2021 | $100M | $400M | VMS Group · Sequoia · Simiao Capital · Primavera Capital Group | ↗ |
| SERIES DOther financing | Dec 2020 | $0 | — | Puhua Capital | — |
Growth signals
Latest recorded traffic for SyMap Medical is 1.7K monthly website visits, up 794.7% over the last three months. SyMap Medical's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
| STShenzhen Saihe Medical TechnologyHealth Tech & Medtech | Ningbo, China | Operational | — | $28M | $110M |
enVVeno MedicalInnovative bioprosthetic solutions for advanced venous disease treatment, featuring first-in-class surgical and transcatheter valves |
New York City, United States | Operational | |||
Core Medical TechnologySpecializes in smart wear and smart medical technology solutions |
Ningbo, China | Operational | |||
Xunjie MedicalFocuses on developing innovative medical devices |
China | Operational | |||
FastWave MedicalAn early-stage medical device company |
Maple Grove, United States | Operational | |||
Synaptic MedicalA medical device company |
Lake Forest, United States | Operational | |||
Jinjiang ElectronicsA med-tech company, engaged in the R&D and manufacture of medical equipment like cardiac electrophysiology |
Chengdu, China | Operational | |||
Arga MedtechDeveloping Cardiac Ablation System for treating cardiac arrhythmias |
Epalinges, Switzerland | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
SyMap Medical in its local ecosystem
The SyMap Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Sequoia
SB China Capital
Series B and later4 investors entered at this stage
- PCPuhua Capital
VMS Group
Primavera Capital Group- SCSimiao Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about SyMap Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SyMap Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








